Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1933 1
1954 1
1957 1
1962 3
1963 1
1964 1
1965 2
1966 1
1967 2
1968 2
1969 3
1970 3
1971 1
1972 4
1973 4
1974 6
1975 5
1976 3
1977 13
1978 4
1979 9
1980 12
1981 10
1982 13
1983 10
1984 9
1985 11
1986 21
1987 15
1988 18
1989 27
1990 33
1991 24
1992 24
1993 28
1994 24
1995 55
1996 37
1997 27
1998 36
1999 26
2000 39
2001 49
2002 51
2003 46
2004 66
2005 85
2006 103
2007 118
2008 109
2009 134
2010 152
2011 153
2012 151
2013 171
2014 228
2015 241
2016 246
2017 257
2018 271
2019 292
2020 348
2021 445
2022 432
2023 501
2024 523
2025 562
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,639 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association.
Cusi K, Abdelmalek MF, Apovian CM, Balapattabi K, Bannuru RR, Barb D, Bardsley JK, Beverly EA, Corbin KD, ElSayed NA, Isaacs S, Kanwal F, Pekas EJ, Richardson CR, Roden M, Sanyal AJ, Shubrook JH, Younossi ZM, Bajaj M. Cusi K, et al. Diabetes Care. 2025 Jul 1;48(7):1057-1082. doi: 10.2337/dci24-0094. Diabetes Care. 2025. PMID: 40434108 Review.
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, El Sayed A, El Ghamrawy A, Damasceno A, Avezum A, Dans AML, Gitura B, Hu D, Kamanzi ER, Maklady F, Fana G, Gonzalez-Hermosillo JA, Musuku J, Kazmi K, Zühlke L, Gondwe L, Ma C, Paniagua M, Ogah OS, Molefe-Baikai OJ, Lwabi P, Chillo P, Sharma SK, Cabral TTJ, Tarhuni WM, Benz A, van Eikels M, Krol A, Pattath D, Balasubramanian K, Rangarajan S, Ramasundarahettige C, Mayosi B, Yusuf S; INVICTUS Investigators. Connolly SJ, et al. Among authors: el sayed a. N Engl J Med. 2022 Sep 15;387(11):978-988. doi: 10.1056/NEJMoa2209051. Epub 2022 Aug 28. N Engl J Med. 2022. PMID: 36036525 Clinical Trial.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Among authors: el sayed h. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
Mortality and Morbidity in Adults With Rheumatic Heart Disease.
Karthikeyan G, Ntsekhe M, Islam S, Rangarajan S, Avezum A, Benz A, Cabral TTJ, Changsheng M, Chillo P, Gonzalez-Hermosillo JA, Gitura B, Damasceno A, Dans AML, Davletov K, Elghamrawy A, ElSayed A, Fana GT, Gondwe L, Haileamlak A, Kayani AM, Lwabi P, Maklady F, Molefe-Baikai OJ, Musuku J, Ogah OS, Paniagua M, Rusingiza E, Sharma SK, Zuhlke L, Connolly S, Yusuf S; INVICTUS Investigators. Karthikeyan G, et al. JAMA. 2024 Jul 9;332(2):133-140. doi: 10.1001/jama.2024.8258. JAMA. 2024. PMID: 38837131 Free PMC article.
Practical Prescribing: Aspirin.
George M, ElSayed S, Magee C, Speechly-Dick ME. George M, et al. BMJ. 2025 Jul 2;390:e081606. doi: 10.1136/bmj-2024-081606. BMJ. 2025. PMID: 40602824 No abstract available.
A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.
Hughes BL, Clifton RG, Rouse DJ, Saade GR, Dinsmoor MJ, Reddy UM, Pass R, Allard D, Mallett G, Fette LM, Gyamfi-Bannerman C, Varner MW, Goodnight WH, Tita ATN, Costantine MM, Swamy GK, Gibbs RS, Chien EK, Chauhan SP, El-Sayed YY, Casey BM, Parry S, Simhan HN, Napolitano PG, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Hughes BL, et al. Among authors: el sayed yy. N Engl J Med. 2021 Jul 29;385(5):436-444. doi: 10.1056/NEJMoa1913569. N Engl J Med. 2021. PMID: 34320288 Free PMC article. Clinical Trial.
Cellulose-based Conductive Materials for Bioelectronics.
Saleh AK, El-Sayed MH, El-Sakhawy MA, Alshareef SA, Omer N, Abdelaziz MA, Jame R, Zheng H, Gao M, Du H. Saleh AK, et al. Among authors: el sayed mh. ChemSusChem. 2025 Mar 15;18(6):e202401762. doi: 10.1002/cssc.202401762. Epub 2024 Nov 15. ChemSusChem. 2025. PMID: 39462209 Review.
ARM IschaEmia Survey (ARMIES).
El-Sayed T, Ali T, Nandhra S, Stather P; ARMIES Research Collaborative. El-Sayed T, et al. Eur J Vasc Endovasc Surg. 2025 Sep;70(3):405-406. doi: 10.1016/j.ejvs.2025.05.026. Epub 2025 May 15. Eur J Vasc Endovasc Surg. 2025. PMID: 40381722 No abstract available.
5,639 results